Decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not inhibited by naloxone in the rat

被引:20
作者
Czapla, MA
Champion, HC
Kadowitz, PJ
机构
[1] TULANE UNIV,SCH MED,DEPT PHARMACOL,NEW ORLEANS,LA 70112
[2] TULANE UNIV,SCH MED,DEPT PHYSIOL,NEW ORLEANS,LA 70112
关键词
nociceptin (orphanin FQ); naloxone; systemic vascular bed; hindquarters vascular bed; hypotensive response;
D O I
10.1016/S0196-9781(97)00178-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nociceptin, the endogenous ligand for the ORL1 receptor, has been shown to decrease systemic arterial and hindquarters perfusion pressures in the rat. The present study was undertaken to determine if decreases in systemic arterial and hindquarters perfusion pressures, in response to nociceptin, are mediated by a naloxone-sensitive mechanism. Injections of nociceptin decreased systemic arterial and hindquarters perfusion pressures in a dose-related manner. The decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin were not altered by the administration of naloxone in a dose of 2 mg/kg IV. Met-enkephalin decreased systemic arterial and hindquarters perfusion pressures and responses to the opioid receptor agonist were significantly reduced by naloxone, whereas decreases in systemic arterial pressure in response to the nitric oxide donor, DEA/NO, were not altered. The results of the present study show that decreases in systemic arterial and hindquarters perfusion pressure in response to nociceptin are not mediated by a naloxone-sensitive mechanism in the rat. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:1197 / 1200
页数:4
相关论文
共 20 条
[1]   MOLECULAR-CLONING AND TISSUE DISTRIBUTION OF A PUTATIVE MEMBER OF THE RAT OPIOID RECEPTOR GENE FAMILY THAT IS NOT A MU-OPIOID, DELTA-OPIOID OR KAPPA-OPIOID RECEPTOR-TYPE [J].
BUNZOW, JR ;
SAEZ, C ;
MORTRUD, M ;
BOUVIER, C ;
WILLIAMS, JT ;
LOW, M ;
GRANDY, DK .
FEBS LETTERS, 1994, 347 (2-3) :284-288
[2]   Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat [J].
Champion, HC ;
Czapla, A ;
Kadowitz, PJ .
PEPTIDES, 1997, 18 (05) :729-732
[3]   Nociceptin, and endogenous ligand for the ORL(1) receptor, has novel hypotensive activity in the rat [J].
Champion, HC ;
Kadowitz, PJ .
LIFE SCIENCES, 1997, 60 (16) :PL241-PL245
[4]   MOLECULAR-CLONING, TISSUE DISTRIBUTION AND CHROMOSOMAL LOCALIZATION OF A NOVEL MEMBER OF THE OPIOID RECEPTOR GENE FAMILY [J].
CHEN, Y ;
FAN, Y ;
LIU, J ;
MESTEK, A ;
TIAN, MT ;
KOZAK, CA ;
YU, L .
FEBS LETTERS, 1994, 347 (2-3) :279-283
[5]   The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line [J].
Connor, M ;
Yeo, A ;
Henderson, G .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) :205-207
[6]   Nociceptin, an endogenous ligand for the ORL1 receptor, has vasodilator activity in the hindquarters vascular bed of the rat [J].
Czapla, MA ;
Champion, HC ;
Kadowitz, PJ .
PEPTIDES, 1997, 18 (06) :793-795
[7]   CDNA CLONING AND REGIONAL DISTRIBUTION OF A NOVEL MEMBER OF THE OPIOID RECEPTOR FAMILY [J].
FUKUDA, K ;
KATO, S ;
MORI, K ;
NISHI, M ;
TAKESHIMA, H ;
IWABE, N ;
MIYATA, T ;
HOUTANI, T ;
SUGIMOTO, T .
FEBS LETTERS, 1994, 343 (01) :42-46
[8]   FUNCTIONAL-ROLE AND SEQUENCE-ANALYSIS OF A LYMPHOCYTE ORPHAN OPIOID RECEPTOR [J].
HALFORD, WP ;
GEBHARDT, BM ;
CARR, DJJ .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 59 (1-2) :91-101
[9]   Structure and regional distribution of nociceptin/orphanin FQ precursor [J].
Houtani, T ;
Nishi, M ;
Takeshima, H ;
Nukada, T ;
Sugimoto, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 219 (03) :714-719
[10]  
Knoflach F, 1996, J NEUROSCI, V16, P6657